Web14 Mar 2024 · Scott Holbrook, PharmaLogic's Chief Strategy Officer and General Manager, stated, "Targeted alpha therapy (TAT) with Pb-212 labeled radioligands offers one of the most exciting platforms for novel cancer therapy within the rapidly expanding precision radiotherapy ecosystem. The expertise of Perspective Therapeutics and PharmaLogic are … Web14 Mar 2024 · Scott Holbrook, PharmaLogic's Chief Strategy Officer and General Manager, stated, "Targeted alpha therapy (TAT) with Pb-212 labeled radioligands offers one of the …
Perspective Therapeutics and PharmaLogic announce …
WebExplore PharmaLogic Holdings' organizational chart. Discover current team members including executives, board members, and advisors. Explore PharmaLogic Holdings' … WebPharmaLogic Holdings Corp., founded in 1993, is an innovative and reliable supplier of radiopharmaceuticals. With over 900 employees currently operating 39 facilities, … facebook kelly
Leadership Team Cardiology Practice Management Company
Web14 Mar 2024 · Scott Holbrook, PharmaLogic's Chief Strategy Officer and General Manager, stated, "Targeted alpha therapy (TAT) with Pb-212 labeled radioligands offers one of the … WebScott Holbrook, MS, FSNMMI-TS – Chief Strategy Officer, General Manager PET & Precision Medicine Scott has over twenty years’ experience in the field of molecular imaging and … Web1 Gordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. 2 Pharmalogic Holdings Corp., Boca Raton, Florida. 3 University of Iowa Hospitals and Clinics, University of Iowa, Iowa City, Iowa. 4 Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia. facebook kelly garcia